NOVARTIS AG (NVSEF)
Clinical trial NCT04023552 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-07-16 3. primary completion date: 2026-06-30 → 2026-07-16
Clinical trial NCT04023552 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-30 → 2026-07-16 3. primary completion date: 2026-06-30 → 2026-07-16
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical